Genetic susceptibility and the common cancers

Biomarkers

Volumn 1, Issue 3, 1996, Pages 174-177

  Caporaso, Neil ^a  

^a ELECTRIC POWER RESEARCH INSTITUTE   (United States)

Author keywords

cancer; gene environment relationship; genetic susceptibility; genetics; molecular Epidemiology

Indexed keywords

EID: 0000823974     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.3109/13547509609079353     Document Type: Article

References (25)

1. Ayesh R., Idle J. R., Ritchie J. C., Crothers M. J., Hetzel M. R. Metabolic oxidation phenotype as markers of susceptibility tdlung cancer. Nature 1984; 312: 169 – 170
2. Bronner C. E., Baker S. M., Morrison P. T., Warren G. L.G., Lescoe M. K., Kane M., Earabwo C, Lipford J., Lindblom A., Tannergard P., Bollag R. J., Godwn A. R., Ward D. C., Norgenskiold M., Fishel R., Kolodner R., Liskay R. M. Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary nompolyposis colon cancer. Nature 1994; 368: 258 – 259
3. Brunner H. G., Nelen M., Breakfield X. O., Ropers H. H., van Oost A. Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase. Science 1993; 262: 578 – 580
4. Caporaso N., Goldstein A. Cancer genes: single and susceptibility: exposing the difference. Pharmacogenetics 1995; 5: 59 – 63
5. Caporaso N., Landi M. T., Vineis P. Relevance of metabolic polymorphisms to human carcinogenesis: evaluation of the epidemiologic evidence. Pharmacogenetics 1991; 1: 4 – 19
6. Caporaso N., DeBaun M. R., Rothman N. Lung cancer and the CYP2D6 (the debrisoquine polymorphism); sources of heterogeneity in the proposed association. Pharmacogenetics 1995; 5: 129 – 134
7. Carter B. S., Beaty T, Steinberg G. D., Childs B., Walsh P. C. Mendelian inheritance of familial prostate cancer. Proceedings of the National Academy of Sciences 1992; 89: 3367 – 3371
8. Clayton E. W., Steinberg K. K., Khoury M. J., Thomson E., Andrews L., Kahn M. E., Kopelman L. M., Weiss J. O. Informed consent for genetic research in stored tissue samples. Journal of the American Medical Association 1995; 274: 1786 – 1792
9. d'Errico, Taiou E., Chen X., Vineis P. Genetic Metabolic Polymorphisms and the Risk of Cancer: A Review of the Literature. Biomarkers, 1: 149 – 173
10. Hayney M. S., Diamanug P., Lipsky J. J., Poland G. A. Utility of a ‘Swish and Spit’ technique for the collection of buccal cells for TAP haplotype determination. Mayo Clinic Proceedings 1995; 70: 951 – 954
11. Hulka B S. Overview of Biological Markers. Biological Markers in Epidemiology. Oxford Universlty Press, New York 1990; 3 – 15
12. Kellermann G., Shaw C. R., Luyten-Kellermann M. Aryl hydrocarbon hydroxylase inducibility and bronchogenic carcinoma. New England Journal of Medicine 1973; 298: 934 – 937
13. Kihara M., Kihara M., Noda K. Lung cancer risk of GSTM1 null genotype is dependent on the extent of tobacco smoke exposure. Caninogenesis 1994; 15: 415 – 418
14. Knudson A. G., Jr. Mutation and cancer-Statistical study of retinoblastoma. Proceedings of the National Academy of Sciences 1971; 68: 820
15. Lower G. M., Nilsson T, Jr., Nelson C. E., Wolf H., Gamskv T. E., Bryan G. T. N-Acetyltransferase phenotype and risk of urinary bladder cancer: approaches in moleculai epidemiology. Environmental Health Perspectives 1979; 29: 71 – 79, Preliminary results in Sweden and Denmark.
16. Miki Y., Swensoen J., Shattuck-Eidens D., Futreal P. A., Harshman K., Tavigian S., Liu Q., Cochran C., Bennett L. M., Ding W., Bell R., Rosenthal J., Hussey C., Tran T., et al. A strong candidate for the breast and ovarian cancer susceptibility gene, Brca1. Science 1994; 266: 66 – 71
17. Nakachi K., Imai K., Hayashi S., Watanabe J., Kawajiri K. Genetic susceptibility to squamous cell carcinoma of the lung in relation to cigarette smoking dose. Cancer Research 1991; 51: 5177 – 5180
18. Polvikoski T, Sulkava R., Haltia M., Kainulainen K., Vuorio A., Verkkoniem A., Ninisto L., Halonen P., Kontula K. Apolipoprotein E, Dementia, and Cortical deposition of B-Amyloid Protein. New England Journal of Medicine 1995; 333: 1242 – 1247
19. Ruz J., Blanche H., James R. W., Garin Blatter, McVaisse C., Charpentier G., Cohen N., Morabia A., Passa P., Froguel P. Gln-Arg192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetes. Lancet 1995; 346: 869 – 872
20. Seidegard J., Pero R. W., Miller D. G., Beattie E. J. A glutathione transferase in human leukocytes as a marker for the susceptibility to lung cancer. Carcinogenesis 1986; 7: 751 – 753
21. Sellers T. A., Baley-Wlson J. E., Elston R. C., Wilson A. F., Elston G. Z., Ooi W L., et al. Evidence for Mendelian Inheritance in the Pathogenesis of Lung Cancer. Journal of the National Cancer Institute 1990; 82: 1272 – 1279
22. Sellers T. A., Chen P-L., Potter J. D., Bailey-Wilson J. E., Rothschild H., Elston R. C. Segregation Analysis of Smoking-Associated Malignancies. American Journal of Medical Genetics 1994; 52: 308 – 314
23. Sugimura H., Caporaso N. E., Modall R., Hoover R. N., Resau J. H., Trump B. F., Longeran J. A., Krontiris T. G., Mann D. L., Weston A., Harris C. C. Association of rare alleles of the Harvey ras protooncogene locus with lung cancer. Cancer Research 1990; 50: 1857 – 1862
24. Vineis P., Caporaso N. Applications of biochemical epidemiology in the study of human carcinogenesis. Tumori 1988; 74: 19 – 26
25. Vineis P., Caporaso N., Tannenbaum S. R., Skipper P. L., Glogowski J., Bartsch H., Coda M., Talaska G., Kadlubar F. Acetylation phenotype, carcinogen-hemoglobin adducts, and cigarette smoking. Cancer Research 1990; 50: 3002 – 3004